Engineered T cells for the treatment of cancer
- 专利权人:
- TCR2 Therapeutics Inc.
- 发明人:
- Getts, Daniel,Patel, Ekta,Baeuerle, Patrick,Hofmeister, Robert
- 申请号：
- AU2017382902
- 公开号：
- AU2017382902A1
- 申请日:
- 2017.12.21
- 申请国别(地区):
- AU
- 年份:
- 2019
- 代理人:
- 摘要：
- Provided herein are T-cell receptor (TCR) fusion proteins (TFPs), T cells engineered to express one or more TFPs, and methods of use thereof for the treatment of diseases, including cancer.
- 来源网站：
- 中国工程科技知识中心
